I-Mab Biopharma, the product of a CBC Group-engineered merger of two Chinese drug developers, has announced plans for a NASDAQ IPO.
CBC – formerly known as C-Bridge Capital – teamed up with traditional Chinese medicine producer Tasly Holding to invest $150 million in the merged entity in 2017. Combining Third Venture Biopharma...
SpaceMarket, a Japanese start-up that lists vacant spaces available for rent for corporate events, is looking to raise up to JPY933.2 million ($8.5 million) through a domestic IPO.
A group of Chinese investors including Gaorong Capital and Sequoia Capital China have joined a $120 million Series B round for Nigerian logistics and payments technology company Opay.
Lumi United, a Chinese smart home appliances and internet-of-things (IoT) solutions provider backed by smart phone maker Xiaomi, has raised $100 million in the third tranche of a Series B funding round.
Advent International has agreed to acquire a controlling position in Bharat Serums and Vaccines, an Indian biopharmaceuticals supplier focused on the women’s health segment.